SPONSOR
iOMEDICO AG
Total Trials
2
Recruiting
2
Phases
N/A
Conditions studied: Polycythemia VeraWaldenström's MacroglobulinemiaChronic Lymphocytic LeukemiaMarginal Zone LymphomaFollicular Lymphoma
iOMEDICO AG is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Polycythemia Vera, Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma.
Studies span multiple clinical phases, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — iOMEDICO AG
How many clinical trials has iOMEDICO AG sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by iOMEDICO AG, of which 2 are actively recruiting participants. These trials cover conditions including Polycythemia Vera, Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does iOMEDICO AG research focus on?
iOMEDICO AG clinical trials span Polycythemia Vera, Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma, Follicular Lymphoma. Sponsor focus areas evolve as trials complete and new programs launch.
How do I participate in a iOMEDICO AG clinical trial?
To participate in a iOMEDICO AG trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all iOMEDICO AG trials with current recruitment status updated daily.
Clinical Trials by iOMEDICO AG
NCT06743035
Recruiting
Ropeginterferon Alfa-2b in Patients With Polycythemia Vera (PV) Without Symptomatic Splenomegaly
Polycythemia Vera
NCT05326308
Recruiting
Zanubrutinib in Patients With Waldenström's Macroglobulinemia, Chronic Lymphocytic Leukemia, Marginal Zone Lymphoma and Follicular Lymphoma
Waldenström's Macroglobulinemia
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology